276 related articles for article (PubMed ID: 34457186)
1. Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease.
Weingarden AR; Rubin SJS; Gubatan J
World J Gastrointest Oncol; 2021 Aug; 13(8):772-798. PubMed ID: 34457186
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint inhibitor-induced colitis: A comprehensive review.
Som A; Mandaliya R; Alsaadi D; Farshidpour M; Charabaty A; Malhotra N; Mattar MC
World J Clin Cases; 2019 Feb; 7(4):405-418. PubMed ID: 30842952
[TBL] [Abstract][Full Text] [Related]
3. New strategies in the diagnosis and treatment of immune-checkpoint inhibitor-mediated colitis.
Velikova T; Krastev B; Gulinac M; Zashev M; Graklanov V; Peruhova M
World J Clin Cases; 2024 Feb; 12(6):1050-1062. PubMed ID: 38464930
[TBL] [Abstract][Full Text] [Related]
4. Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimics.
Cassol CA; Owen D; Kendra K; Braga JR; Frankel WL; Arnold CA
Histopathology; 2020 Aug; 77(2):240-249. PubMed ID: 32298485
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint inhibitor-mediated colitis is associated with cancer overall survival.
Weingarden AR; Gubatan J; Singh S; Balabanis TC; Patel A; Sharma A; Habtezion A
World J Gastroenterol; 2022 Oct; 28(39):5750-5763. PubMed ID: 36338892
[TBL] [Abstract][Full Text] [Related]
6. Checkpoint Inhibitor-Induced Colitis.
Bellaguarda E; Hanauer S
Am J Gastroenterol; 2020 Feb; 115(2):202-210. PubMed ID: 31922959
[TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis and management of immune checkpoint inhibitor-induced colitis: A comprehensive review.
Li H; Fu ZY; Arslan ME; Cho D; Lee H
World J Exp Med; 2021 Dec; 11(6):79-92. PubMed ID: 36246150
[TBL] [Abstract][Full Text] [Related]
8. Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.
Middha P; Thummalapalli R; Betti MJ; Yao L; Quandt Z; Balaratnam K; Bejan CA; Cardenas E; Falcon CJ; Faleck DM; ; Gubens MA; Huntsman S; Johnson DB; Kachuri L; Khan K; Li M; Lovly CM; Murray MH; Patel D; Werking K; Xu Y; Zhan LJ; Balko JM; Liu G; Aldrich MC; Schoenfeld AJ; Ziv E
Nat Commun; 2024 Mar; 15(1):2568. PubMed ID: 38531883
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis.
Westdorp H; Sweep MWD; Gorris MAJ; Hoentjen F; Boers-Sonderen MJ; van der Post RS; van den Heuvel MM; Piet B; Boleij A; Bloemendal HJ; de Vries IJM
Front Immunol; 2021; 12():768957. PubMed ID: 34777387
[TBL] [Abstract][Full Text] [Related]
10. Immune-Mediated Colitis.
Menon T; Afzali A
Curr Treat Options Gastroenterol; 2019 Dec; 17(4):506-523. PubMed ID: 31741212
[TBL] [Abstract][Full Text] [Related]
11. Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis.
Abu-Sbeih H; Herrera LN; Tang T; Altan M; Chaftari AP; Okhuysen PC; Jenq RR; Wang Y
J Immunother Cancer; 2019 Sep; 7(1):242. PubMed ID: 31488205
[TBL] [Abstract][Full Text] [Related]
12. Immune checkpoint inhibitor-induced colitis complicated with inflammatory intestinal obstruction: a case report and literature review.
Tan S; Zhu G; Fan J; Chen J; Li X; Peng Y; Su S; Fang C; Yang X; Li B
Transl Cancer Res; 2022 Jul; 11(7):2443-2448. PubMed ID: 35966294
[TBL] [Abstract][Full Text] [Related]
13. Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases.
Meserve J; Facciorusso A; Holmer AK; Annese V; Sandborn WJ; Singh S
Aliment Pharmacol Ther; 2021 Feb; 53(3):374-382. PubMed ID: 33314269
[TBL] [Abstract][Full Text] [Related]
14. Immune-related adverse events in the gastrointestinal tract: diagnostic utility of upper gastrointestinal biopsies.
Zhang ML; Neyaz A; Patil D; Chen J; Dougan M; Deshpande V
Histopathology; 2020 Jan; 76(2):233-243. PubMed ID: 31361907
[TBL] [Abstract][Full Text] [Related]
15. Safety of Immune Checkpoint Inhibitors in Patients With Pre-Existing Inflammatory Bowel Disease and Microscopic Colitis.
Grover S; Ruan AB; Srivoleti P; Giobbie-Hurder A; Braschi-Amirfarzan M; Srivastava A; Buchbinder EI; Ott PA; Kehl KL; Awad MM; Hodi FS; Rahma OE
JCO Oncol Pract; 2020 Sep; 16(9):e933-e942. PubMed ID: 32401685
[TBL] [Abstract][Full Text] [Related]
16. Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID.
Amiot A; Laharie D; Malamut G; Serrero M; Poullenot F;
Dig Liver Dis; 2022 Sep; 54(9):1162-1167. PubMed ID: 35842365
[TBL] [Abstract][Full Text] [Related]
17. Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.
Middha P; Thummalapalli R; Betti MJ; Yao L; Quandt Z; Balaratnam K; Bejan CA; Cardenas E; Falcon CJ; Faleck DM; ; Gubens MA; Huntsman S; Johnson DB; Kachuri L; Khan K; Li M; Lovly CM; Murray MH; Patel D; Werking K; Xu Y; Zhan LJ; Balko JM; Liu G; Aldrich MC; Schoenfeld AJ; Ziv E
medRxiv; 2023 Sep; ():. PubMed ID: 37292751
[TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations.
Remon J; Passiglia F; Ahn MJ; Barlesi F; Forde PM; Garon EB; Gettinger S; Goldberg SB; Herbst RS; Horn L; Kubota K; Lu S; Mezquita L; Paz-Ares L; Popat S; Schalper KA; Skoulidis F; Reck M; Adjei AA; Scagliotti GV
J Thorac Oncol; 2020 Jun; 15(6):914-947. PubMed ID: 32179179
[TBL] [Abstract][Full Text] [Related]
19. Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management.
Shivaji UN; Jeffery L; Gui X; Smith SCL; Ahmad OF; Akbar A; Ghosh S; Iacucci M
Therap Adv Gastroenterol; 2019; 12():1756284819884196. PubMed ID: 31723355
[TBL] [Abstract][Full Text] [Related]
20. Flexible sigmoidoscopy may be sufficient for initial evaluation of suspected immunotherapy-mediated colitis: A cross-sectional study.
De Silva S; Trieu H; Rajan A; Liang Y; Lin JL; Kidambi TD
J Gastroenterol Hepatol; 2022 Feb; 37(2):284-290. PubMed ID: 34547818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
